WEIDAI LTD-ADR (WEI) Fundamental Analysis & Valuation

NYSE:WEI • US94861A2078

Current stock price

0.96
+0.03 (+3.23%)
Last:

This WEI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. WEI Profitability Analysis

1.1 Basic Checks

  • In the past year WEI has reported negative net income.
WEI Yearly Net Income VS EBIT VS OCF VS FCFWEI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 1B -1B 2B

1.2 Ratios

Industry RankSector Rank
ROA -95.08%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WEI Yearly ROA, ROE, ROICWEI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -100 -200

1.3 Margins

Industry RankSector Rank
OM -104.27%
PM (TTM) -160.42%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WEI Yearly Profit, Operating, Gross MarginsWEI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. WEI Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for WEI remains at a similar level compared to 1 year ago.
  • WEI has a better debt/assets ratio than last year.
WEI Yearly Shares OutstandingWEI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M
WEI Yearly Total Debt VS Total AssetsWEI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2B 4B 6B

2.2 Solvency

  • WEI has an Altman-Z score of -1.66. This is a bad value and indicates that WEI is not financially healthy and even has some risk of bankruptcy.
  • WEI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.66
ROIC/WACCN/A
WACCN/A
WEI Yearly LT Debt VS Equity VS FCFWEI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 1B -1B 2B

2.3 Liquidity

  • WEI has a Current Ratio of 1.51. This is a normal value and indicates that WEI is financially healthy and should not expect problems in meeting its short term obligations.
  • A Quick Ratio of 1.51 indicates that WEI should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51
WEI Yearly Current Assets VS Current LiabilitesWEI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. WEI Growth Analysis

3.1 Past

  • WEI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -60.16%.
  • WEI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -54.47%.
  • The Revenue for WEI have been decreasing by -16.68% on average. This is quite bad
EPS 1Y (TTM)-60.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-226.48%
Revenue 1Y (TTM)-54.47%
Revenue growth 3Y-44.19%
Revenue growth 5Y-16.68%
Sales Q2Q%-73.99%

3.2 Future

  • The Earnings Per Share is expected to decrease by -28.88% on average over the next years. This is quite bad
  • The Revenue is expected to decrease by -28.05% on average over the next years. This is quite bad
EPS Next Y-79.78%
EPS Next 2Y-55.03%
EPS Next 3Y-28.88%
EPS Next 5YN/A
Revenue Next Year-32.99%
Revenue Next 2Y-32.49%
Revenue Next 3Y-28.05%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
WEI Yearly Revenue VS EstimatesWEI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B
WEI Yearly EPS VS EstimatesWEI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

2

4. WEI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for WEI. In the last year negative earnings were reported.
  • WEI is valuated cheaply with a Price/Forward Earnings ratio of 2.01.
  • WEI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.42.
Industry RankSector Rank
PE N/A
Fwd PE 2.01
WEI Price Earnings VS Forward Price EarningsWEI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.09
WEI Per share dataWEI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

  • WEI's earnings are expected to decrease with -28.88% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-55.03%
EPS Next 3Y-28.88%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. WEI Dividend Analysis

5.1 Amount

  • WEI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

WEI Fundamentals: All Metrics, Ratios and Statistics

WEIDAI LTD-ADR

NYSE:WEI (5/16/2022, 8:04:00 PM)

0.96

+0.03 (+3.23%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.09%
Inst Owner Change-15.44%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap67.64M
Revenue(TTM)711.06M
Net Income(TTM)-1.14B
Analysts42.5
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.01
P/S 0.64
P/FCF N/A
P/OCF N/A
P/B 1.04
P/tB N/A
EV/EBITDA -0.09
EPS(TTM)-2.42
EYN/A
EPS(NY)0.48
Fwd EY49.71%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.51
BVpS0.92
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -95.08%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -104.27%
PM (TTM) -160.42%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z -1.66
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-60.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-226.48%
EPS Next Y-79.78%
EPS Next 2Y-55.03%
EPS Next 3Y-28.88%
EPS Next 5YN/A
Revenue 1Y (TTM)-54.47%
Revenue growth 3Y-44.19%
Revenue growth 5Y-16.68%
Sales Q2Q%-73.99%
Revenue Next Year-32.99%
Revenue Next 2Y-32.49%
Revenue Next 3Y-28.05%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

WEIDAI LTD-ADR / WEI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for WEIDAI LTD-ADR?

ChartMill assigns a fundamental rating of 2 / 10 to WEI.


What is the valuation status of WEIDAI LTD-ADR (WEI) stock?

ChartMill assigns a valuation rating of 3 / 10 to WEIDAI LTD-ADR (WEI). This can be considered as Overvalued.


Can you provide the profitability details for WEIDAI LTD-ADR?

WEIDAI LTD-ADR (WEI) has a profitability rating of 1 / 10.


How financially healthy is WEIDAI LTD-ADR?

The financial health rating of WEIDAI LTD-ADR (WEI) is 3 / 10.


Is the dividend of WEIDAI LTD-ADR sustainable?

The dividend rating of WEIDAI LTD-ADR (WEI) is 0 / 10 and the dividend payout ratio is 0%.